BMC cancer

Keyphrases

Publications

volume 24, number 1, 2024

Wang Qu, Zimin Liu, Xiaobing Chen, Bo Liu, YunBo Zhao, Hao Yan, Xiujuan Qu, Shengmian Li, Aimin Zang, Yongkun Sun, Liangjun Zhu, Aiping Zhou
Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China. BMC cancer 24 (1) (2024)
Alejandro Aranda-Gutierrez, Ana S Ferrigno Guajardo, Bryan F Vaca-Cartagena, David G Gonzalez-Sanchez, Arantxa Ramirez-Cisneros, Andrea Becerril-Gaitan, Hatem A Azim, Cynthia Villarreal-Garza
Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review. BMC cancer 24 (1) (2024)
Shuang Zhao, Miao Miao, Qingqing Wang, Haijuan Zhao, Han Yang, Xin Wang
The current status of clinical trials on cancer and age disparities among the most common cancer trial participants. BMC cancer 24 (1) (2024)
Shuangshuang Zhao, Minmin Zhang, Qing Zhang, Jingjun Wu, Hui Dai
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial. BMC cancer 24 (1) (2024)
Shuangshuang Zhao, Minmin Zhang, Qing Zhang, Jingjun Wu, Hui Dai
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial. BMC cancer 24 (1) (2024)
Farah Choulli, Hassan Abdelilah Tafenzi, Faiçal El Hattimy, Mohamed Khaled Choulli, Rhizlane Belbaraka
Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study : Mohammed VI University Hospital, Medical Oncology Department, Marrakech, Morocco. BMC cancer 24 (1) (2024)
Jiaoyu Ai, Wanlin Zhang, Wensheng Deng, Likun Yan, Lidong Zhang, Zongjing Huang, Ziyi Wu, Junhua Ai, Hai Jiang
A hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma. BMC cancer 24 (1) (2024)
Xin Xu, Wei Zhao, Cuicui Liu, Yongsheng Gao, Dawei Chen, Meng Wu, Chao Li, Xinzhao Wang, Xiang Song, Jinming Yu, Zhaoyun Liu, Zhiyong Yu
The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy. BMC cancer 24 (1) (2024)
Xuming Zhou, Keqiang Chai, Hezhen Zhu, Cong Luo, Xiaofeng Zou, Junrong Zou, Guoxi Zhang
The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target. BMC cancer 24 (1) (2024)
Su Jung Lee, Dal-Lae Jin, Young Ae Kim, Hyun-Ju Seo, Seok-Jun Yoon
Correction: How should the healthcare system support cancer survivors? Survivors' and health professionals' expectations and perception on comprehensive cancer survivorship care in Korea: a qualitative study. BMC cancer 24 (1) (2024)
Xiayang Ren, Guanmin Zhang, Guohui Li, Yanfeng Wang
Chimeric antigen receptor T-cell therapy-induced nervous system toxicity: a real-world study based on the FDA Adverse Event Reporting System database. BMC cancer 24 (1) (2024)
Xiewei Huang, Yushuai Yu, Shiping Luo, Wenfen Fu, Jie Zhang, Chuangui Song
The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis. BMC cancer 24 (1) (2024)
Xuming Zhou, Keqiang Chai, Hezhen Zhu, Cong Luo, Xiaofeng Zou, Junrong Zou, Guoxi Zhang
The role of the methyltransferase METTL3 in prostate cancer: a potential therapeutic target. BMC cancer 24 (1) (2024)
Xiewei Huang, Yushuai Yu, Shiping Luo, Wenfen Fu, Jie Zhang, Chuangui Song
The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis. BMC cancer 24 (1) (2024)
Kaili Yu, Shuang Liu, Zheng Lin, Jianyu Song, Qiaoyan Zeng, Jinsong Zhou, Juwei Zhang, Suhong Zhang, Jianbo Lin, Zhisheng Xiang, Zhijian Hu
Effect of trace element mixtures on the outcome of patients with esophageal squamous cell carcinoma: a prospective cohort study in Fujian, China. BMC cancer 24 (1) (2024)
Anais Oudin, Pilar M Moreno-Sanchez, Virginie Baus, Simone P Niclou, Anna Golebiewska
Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence. BMC cancer 24 (1) (2024)
Qinsong Liu, Yong Yuan, Xiaofen Shang, Lu Xin
Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma. BMC cancer 24 (1) (2024)
Wei Wang, Wenqian Lei, Ziru Fang, Ruiyuan Jiang, Xiaojia Wang
Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer. BMC cancer 24 (1) (2024)
Linda Setiawan, Katy Graef, Dan Schmolze, Alemwosen Alem, Lesley Taylor
Building pathology capacity in sub-Saharan Africa to improve breast cancer diagnosis and treatment: training laboratory technicians in high-quality manual immunohistochemistry. BMC cancer 24 (1) (2024)
Xiayang Ren, Guanmin Zhang, Guohui Li, Yanfeng Wang
Chimeric antigen receptor T-cell therapy-induced nervous system toxicity: a real-world study based on the FDA Adverse Event Reporting System database. BMC cancer 24 (1) (2024)
Majid Ghasemian, Mojtaba Zehtabi, Mahrokh Abouali Gale Dari, Fatemeh Khojasteh Pour, Ghasem Azizi Tabesh, Farideh Moramezi, Razieh Mohammad Jafari, Mojgan Barati, Shahab Uddin, Maryam Farzaneh
The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. BMC cancer 24 (1) (2024)
Xiao-Chun Wang, Ling Zhang, Jiong-Bin Lin, Xiao-Yao Huang, Jing-Hong Liang, Jian-Ping Zhong, Ji-Dong Peng, Jun-Yuan Zhong
Imaging diagnosis and differential diagnosis of extraskeletal osteosarcoma. BMC cancer 24 (1) (2024)
Yuehong Chen, Feng Liu, Xinhua Chen, Wenyi Li, Kejun Li, Hailang Cai, Shunyi Wang, Honglei Wang, Ke Xu, Chenxi Zhang, Shengzhi Ye, Yunhao Shen, Tingyu Mou, Shumin Cai, Jianwei Zhou, Jiang Yu
microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation. BMC cancer 24 (1) (2024)
Tong Qu, Shaopeng Zhang, Shaokang Yang, Shuang Li, Daguang Wang
Utilizing serum metabolomics for assessing postoperative efficacy and monitoring recurrence in gastric cancer patients. BMC cancer 24 (1) (2024)
Fang Zhou, Meng Wang, Zheng Wang, Wei Li, Xike Lu
Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes. BMC cancer 24 (1) (2024)
Lipan Wei, Xiuqian Wu, Lan Wang, Ling Chen, Xuejun Wu, Tiantian Song, Yuanyuan Wang, Wenjun Chang, Aizhen Guo, Yongdong Niu, Haihua Huang
Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells. BMC cancer 24 (1) (2024)
Eileen Owens, Lauren Harris, Adam Harris, Janna Yoshimoto, Robert Burnett, Anne Avery
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma. BMC cancer 24 (1) (2024)
Chan Wang, Yanjie Hou, Lili Wang, Ye Yang, Xianfeng Li
Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors. BMC cancer 24 (1) (2024)
Xiao-Chun Wang, Ling Zhang, Jiong-Bin Lin, Xiao-Yao Huang, Jing-Hong Liang, Jian-Ping Zhong, Ji-Dong Peng, Jun-Yuan Zhong
Imaging diagnosis and differential diagnosis of extraskeletal osteosarcoma. BMC cancer 24 (1) (2024)
Majid Ghasemian, Mojtaba Zehtabi, Mahrokh Abouali Gale Dari, Fatemeh Khojasteh Pour, Ghasem Azizi Tabesh, Farideh Moramezi, Razieh Mohammad Jafari, Mojgan Barati, Shahab Uddin, Maryam Farzaneh
The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. BMC cancer 24 (1) (2024)
Fang Zhou, Meng Wang, Zheng Wang, Wei Li, Xike Lu
Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes. BMC cancer 24 (1) (2024)
Tong Qu, Shaopeng Zhang, Shaokang Yang, Shuang Li, Daguang Wang
Utilizing serum metabolomics for assessing postoperative efficacy and monitoring recurrence in gastric cancer patients. BMC cancer 24 (1) (2024)
Eileen Owens, Lauren Harris, Adam Harris, Janna Yoshimoto, Robert Burnett, Anne Avery
The gene expression profile and cell of origin of canine peripheral T-cell lymphoma. BMC cancer 24 (1) (2024)
Yuehong Chen, Feng Liu, Xinhua Chen, Wenyi Li, Kejun Li, Hailang Cai, Shunyi Wang, Honglei Wang, Ke Xu, Chenxi Zhang, Shengzhi Ye, Yunhao Shen, Tingyu Mou, Shumin Cai, Jianwei Zhou, Jiang Yu
microRNA-622 upregulates cell cycle process by targeting FOLR2 to promote CRC proliferation. BMC cancer 24 (1) (2024)
Yafeng Liu, Tao Han, Rui Miao, Jiawei Zhou, Jianqiang Guo, Zhi Xu, Yingru Xing, Ying Bai, Jing Wu, Dong Hu
RACGAP1 promotes the progression and poor prognosis of lung adenocarcinoma through its effects on the cell cycle and tumor stemness. BMC cancer 24 (1) (2024)
Fatemeh Mohajerani, Zahra Moazezi Tehrankhah, Saeid Rahmani, Nastaran Afsordeh, Sajad Shafiee, Mohammad Hossein Pourgholami, Bahram M Soltani, Majid Sadeghizadeh
CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme. BMC cancer 24 (1) (2024)
Fatemeh Tabatabaei, Saghar Babadi, Shima Nourigheimasi, Arshin Ghaedi, Monireh Khanzadeh, Aida Bazrgar, Morad Kohandel Gargari, Shokoufeh Khanzadeh
Neutrophil to lymphocyte ratio as an assessment tool to differentiate between uterine sarcoma and myoma: a systematic review and meta-analysis. BMC cancer 24 (1) (2024)
Stefania Crucitta, Francesco Pasqualetti, Alessandra Gonnelli, Martina Ruglioni, Giovanna Irene Luculli, Martina Cantarella, Valerio Ortenzi, Cristian Scatena, Fabiola Paiar, Antonio Giuseppe Naccarato, Romano Danesi, Marzia Del Re
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients. BMC cancer 24 (1) (2024)
Alona Kolnohuz, Leyla Ebrahimpour, Sevinj Yolchuyeva, Venkata S K Manem
Gene expression signature predicts radiation sensitivity in cell lines using the integral of dose-response curve. BMC cancer 24 (1) (2024)
Yongfeng Wang, Hong Jiang, Liangyin Fu, Ling Guan, Jiaxin Yang, Jingyao Ren, Fangyu Liu, Xiangyang Li, Xuhui Ma, Yonghong Li, Hui Cai
Prognostic value and immunological role of PD-L1 gene in pan-cancer. BMC cancer 24 (1) (2024)
Xuemin Xue, Lei Guo, Changyuan Guo, Lin Li, Lin Yang, Xin Wang, Wei Rao, Pei Yuan, Jiali Mu, Jiangtao Li, Bingning Wang, Quan Zhou, Wentao Yang, Yueping Liu, Weicheng Xue, Rujing Jia, Wenjing Yang, Jianming Ying
Proficiency testing of diagnosis in histopathology and immunohistochemistry of breast pathology in China: results from a pilot work of National Single Disease Quality Control Program for breast cancer. BMC cancer 24 (1) (2024)
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen, Melike Özçelik, Ali Arıcan, Baran Akagündüz, Ali İnal, Dinçer Aydın, Leyla Özer, Ahmet Gülmez, Nazım Serdar Turhal, Selin Aktürk Esen, Efnan Algın, Sinem Akbaş, Yakup İriağaç, Teoman Şakalar, Çağlar Ünal, Özlem Er, Şaban Seçmeler, Mustafa Bozkurt
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer. BMC cancer 24 (1) (2024)
Lipan Wei, Xiuqian Wu, Lan Wang, Ling Chen, Xuejun Wu, Tiantian Song, Yuanyuan Wang, Wenjun Chang, Aizhen Guo, Yongdong Niu, Haihua Huang
Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells. BMC cancer 24 (1) (2024)
Chan Wang, Yanjie Hou, Lili Wang, Ye Yang, Xianfeng Li
Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors. BMC cancer 24 (1) (2024)
Xuemin Xue, Lei Guo, Changyuan Guo, Lin Li, Lin Yang, Xin Wang, Wei Rao, Pei Yuan, Jiali Mu, Jiangtao Li, Bingning Wang, Quan Zhou, Wentao Yang, Yueping Liu, Weicheng Xue, Rujing Jia, Wenjing Yang, Jianming Ying
Proficiency testing of diagnosis in histopathology and immunohistochemistry of breast pathology in China: results from a pilot work of National Single Disease Quality Control Program for breast cancer. BMC cancer 24 (1) (2024)
Alejandro Aranda-Gutierrez, Ana S Ferrigno Guajardo, Bryan F Vaca-Cartagena, David G Gonzalez-Sanchez, Arantxa Ramirez-Cisneros, Andrea Becerril-Gaitan, Hatem A Azim, Cynthia Villarreal-Garza
Obstetric and neonatal outcomes following taxane use during pregnancy: a systematic review. BMC cancer 24 (1) (2024)
Elif Şenocak Taşçı, Başak Oyan, Özlem Sönmez, Arda Ulaş Mutlu, Muhammed Mustafa Atcı, Abdullah Sakin, İrem Öner, Havva Yeşil Çınkır, Melek Karakurt Eryılmaz, Dilek Çağlayan, Onur Yazdan Balçık, Nail Paksoy, Senem Karabulut, Derya Kıvrak Salim, Cemil Bilir, Miraç Özen, Melike Özçelik, Ali Arıcan, Baran Akagündüz, Ali İnal, Dinçer Aydın, Leyla Özer, Ahmet Gülmez, Nazım Serdar Turhal, Selin Aktürk Esen, Efnan Algın, Sinem Akbaş, Yakup İriağaç, Teoman Şakalar, Çağlar Ünal, Özlem Er, Şaban Seçmeler, Mustafa Bozkurt
Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer. BMC cancer 24 (1) (2024)
Kaili Yu, Shuang Liu, Zheng Lin, Jianyu Song, Qiaoyan Zeng, Jinsong Zhou, Juwei Zhang, Suhong Zhang, Jianbo Lin, Zhisheng Xiang, Zhijian Hu
Effect of trace element mixtures on the outcome of patients with esophageal squamous cell carcinoma: a prospective cohort study in Fujian, China. BMC cancer 24 (1) (2024)
Farah Choulli, Hassan Abdelilah Tafenzi, Faiçal El Hattimy, Mohamed Khaled Choulli, Rhizlane Belbaraka
Chemotherapy-related adverse effects with anthracycline and taxane-containing regimens in patients with localized Breast cancer: a descriptive study : Mohammed VI University Hospital, Medical Oncology Department, Marrakech, Morocco. BMC cancer 24 (1) (2024)
Wang Qu, Zimin Liu, Xiaobing Chen, Bo Liu, YunBo Zhao, Hao Yan, Xiujuan Qu, Shengmian Li, Aimin Zang, Yongkun Sun, Liangjun Zhu, Aiping Zhou
Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China. BMC cancer 24 (1) (2024)